Skip to main content
. 2021 Aug 31;13(9):1373. doi: 10.3390/pharmaceutics13091373

Figure 3.

Figure 3

Schematic illustration representing 3D bioprinting, enabling the establishment of 3D cell culture devices, including organoid, organ-on-a-chip, and tissue/organ equivalent, that can advance pharmaceutical applications of drug discovery, drug screening, and disease modeling. This figure was prepared using a template on the Sevier medical art website (http://www.sevier.fr/sevier-medical-art, accessed on 12 July 2021).